You are here
Articles
Posted on Wednesday, November 4, 2009 - 6:22pm
Conversation With Brian J. Druker, M.D.
Posted on Wednesday, November 4, 2009 - 6:08pm
Posted on Thursday, October 22, 2009 - 11:16am
The Peninsula Health Technology Commissioning Group (PHTCG) has come to a decision on the use of dasatinib and nilotinib in the management of chronic myeloid leukaemia.
Posted on Monday, October 19, 2009 - 2:10pm
e-cancer -Insider News
Discovery offers hope for new cancer treatments
Published: 06/10/2009 11:50:40
Scientists have discovered why a group of cancer drugs are so effective in treating the disease. Although they have...
Posted on Thursday, October 15, 2009 - 11:34am
Dear friends,
Welcome to the grand opening of our virtual art exhibit, the Colors of Hope Gallery! Admission to the online exhibit is absolutely free!!
Posted on Friday, October 2, 2009 - 11:25am
EMEA website provides information about the role and activities of the European Medicines Agency in relation to the current H1N1 influenza ('swine flu') pandemic. It also provides information on the development and...
Posted on Friday, August 14, 2009 - 2:36pm
Poster for CML Patient and Carer Education Day
14th November 2009 at
The Crown Plaza Hotel, Nottingham, UK...
Posted on Tuesday, August 11, 2009 - 11:39am
Capsule Summary
CCO-Independent Conference Coverage of the American Society of Clinical Oncology Annual Meeting, June 2009*Omacetaxine Active With Minimal Toxicity in T315I-...
Posted on Friday, July 17, 2009 - 12:03pm
Cutting-edge drugs to be fast-tracked, bypassing NICE
15 July 2009
The UK government has announced plans to allow highly innovative drugs to be made available on the NHS for a limited period without going through...
Posted on Monday, June 29, 2009 - 1:53pm
At 24th of June 2009 a new campaign European Action Against Rare Cancers has been launched. The new campaign urges European policy-makers to prioritise better treatment and care for patients with rare cancers within the...
Posted on Thursday, June 18, 2009 - 12:23pm
May 22 (HealthDay News) -- Low levels of vitamin D may contribute to cancer development, U.S. researchers have found.
Posted on Friday, June 12, 2009 - 11:23am
Interim guidance for use of 23-valent pneumococcal polysaccharide vaccine during novel influenza A (H1N1) outbreak
June 9, 2009
Table. U.S. ACIP recommendations for use of pneumococcal polysaccacharide vaccine.
Posted on Tuesday, June 9, 2009 - 12:07pm
Persistent CML-initiating cells, or CML stem cells, which are protected from imatinib killing by their quiescent status, are
probably responsible for the regrowth of the disease.
Posted on Tuesday, June 2, 2009 - 10:32am
Life Extension Magazine
June 2, 2009
New model of cancer development proposed
In an article scheduled to appear in the Annals of Epidemiology, epidemiologist Cedric Garland, DrPH and his associates at the University of...
- ‹ previous
- 23 of 29
- next ›